Additionally, it is worth noting that individuals with MASLD who exhibit high levels of IHTG were unable to inhibit the release of VLDL particles and apoB100 protein effectively during a clamp, indicative of insulin resistance in the liver [198]. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.